Advertisement

Topics

Drugmaker Hikma's U.S. unit raises medicine prices: Financial Times

10:53 EDT 20 Aug 2017 | Reuters

NEW YORK (Reuters) - Hikma Pharmaceuticals Plc's U.S. subsidiary has raised the price of a common diarrhea drug by more than 400 percent and is charging more for five other medicines as well, the Financial Times reported on Sunday.

Original Article: Drugmaker Hikma's U.S. unit raises medicine prices: Financial Times

NEXT ARTICLE

More From BioPortfolio on "Drugmaker Hikma's U.S. unit raises medicine prices: Financial Times"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...